Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL By efrat|2022-09-21T08:19:47+00:00September 21st, 2022|All|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: efrat Related Posts Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis Prof. Paul Richardson – Melflufen for the treatement of relapsed-refractory myeloma Prof. Paul Richardson – Melflufen for the treatement of relapsed-refractory myeloma
